📰 First Trade Under News
First Trade Under News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from First Trade Under. Real-time updates on events, politics, business and more.
March 26, 2024
ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply, and distribution rights.
March 26, 2024
Evercore ISI Group analyst Michael Montani maintained Carvana with an In-Line rating and raised the price target on the stock from $68 to $75 Tuesday. Carvana received two significant analyst upgrades earlier in March, one from Jefferies analyst John Colantuoni who upgraded Carvana from an Underperform to a Hold rating and raised the price target from $30 to $85. RBC Capital analyst Brad Erickson also upgraded the stock from Underperform to Sector Perform and raised its price target from $45 to ...
March 26, 2024
The company announced the release of MicroStrategy Auto on Tuesday. MicroStrategy describes Auto as a customizable AI bot that offers a faster, simpler way to deliver business intelligence to anyone in an organization and the latest enhancement to MicroStrategy AI, released in October 2023, a solution for rapidly building AI applications on trusted data.
March 26, 2024
Rumble shares are trading higher Tuesday, possibly in sympathy with Trump Media & Technology Group Corp. after the company debuted on the Nasdaq Tuesday. Trump Media & Technology Group made its debut on the Nasdaq Tuesday and is trading up 35% at the time of publication.
March 26, 2024
Shockwave Medical shares are trading higher Tuesday following a report suggesting Johnson & Johnson is in talks to acquire the company. According to a report from the Wall Street Journal, people familiar with the matter say that a deal to acquire the company could be completed in the coming weeks. Shockwave Medical shares have gained more than 65% year-to-date, and the company has a market value of nearly $11 billion.
March 26, 2024
Last week, the German government partially legalized cannabis, and Canopy Growth shares lit up. Canopy Growth CEO David Klein joined BNN Bloomberg on Friday and discussed the effects of the legislation for the company. Klein sees Germany's cannabis market growing from its current value of just under $500 million to an over $2.5 billion market in the next 2 years.